patients

Agyany is the dedicated partner for all Parkinson’s patients. We specialize in developing innovative and modern therapies for the treatment of Parkinson’s disease, with a primary focus on patients with the GBA1 variant.

Our commitment to patients

Together with patients, we are actively shaping a brighter future. Our objective is to achieve this through collaborative partnerships because we firmly believe that "Together, we are better." We are at the forefront of efforts to deepen our understanding of the root causes of Parkinson's Disease. Our team comprises clinicians, scientists, biotechnologists, and chemists who not only listen to patients and stakeholders but also strive to comprehend your stories with the aim of providing meaningful solutions to your challenges. Agyany shares a collective mission driven by your resilience, and we eagerly embrace the opportunity to accompany you on this journey.

testimonials

J.S , Australia

"Joleen Istaiti is a remarkable example of a fine human being combined with an efficient and thoughtful member of the research community. She is a delightful person with whom to work and she will always bring something positive, forward-looking and new to the table. She is an asset to the research community and business and I am sure is to this company."

S.S , USA

"I'm very pleased with my response to ambroxol! My handwriting has improved, and my fingers are moving comfortably on my computer keyboard. I am very hopeful and extremely appreciative of Ari's efforts in the field of Parkinson's disease."

D.E , Israel

Ari Zimran and Arndt Rolfs are exceptional medical pioneers, known for their unwavering commitment to ethical care and their expertise in diagnostic and innovative laboratory methodologies. They have successfully opened doors for patients, embodying the best in the science and the art of medicine.

T.T , Georgia

"I've had the privilege of collaborating with Agyany's founders for years. Their expertise in rare disease diagnostics and biomarker discovery has earned the trust of thousands worldwide! The Agyany team are reliable, trustworthy partners, deeply passionate about enhancing the health and quality of life for rare disease and Parkinson's patients and their families."

clinical trials

AGPI; Agyany Parkinson I

patients access

Agyany is dedicated to enhancing the well-being of individuals with PD and those at a heightened genetic risk of developing PD. Our commitment involves collaborating closely with patients and stakeholders, actively engaging with your narratives. Your words and stories serve as powerful catalysts, inspiring us to deepen our comprehension of PD's root causes and explore innovative treatment alternatives for a broader patient population.

While we firmly believe that participation in a clinical trial represents the optimal pathway to access new treatments, we recognize that this may not be feasible for every patient. In such situations, Agyany may consider the possibility of making compounds, such as ambroxol, available outside of a clinical trial.

Picture of a patient helped by our staff

By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.

Preferences Deny Accept